TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. We live in an increasing data-rich world, where forward-thinking organizations are harnessing the ...
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that multiple ...
SAN JOSE, CA, UNITED STATES, February 24, 2026 / EINPresswire.com / — TapClicks, the leader in Smart Marketing solutions, ...
Hunter syndrome (MPS II) presentations will include analysis from continued follow-up of Phase 1/2 data for tividenofusp alfa (DNL310), currently under FDA Priority Review Preliminary data from Phase ...
Today at Adobe's annual digital innovation conference Summit 2024 in Las Vegas, the company is unveiling Project Slide Wow, a generative AI-driven tool designed to streamline the creation of ...
Our PowerPoint guide outlines everything you should include in your slide deck, with tips on preparing effective ...
Twelve-month data from the VOLT-AF Global IDE study found that the Volt PFA System had an industry-leading success rate (84.2%) of freedom from documented rhythm recurrence among all competitive PFA ...